Exploring 3 High Growth Tech Stocks in US Market

Larimar Therapeutics Announces Investor Event on the Nomlabofusp Program for Friedreich’s Ataxia

Larimar Therapeutics Reports Positive Open Label Data and Submission of First Module of Rolling BLA for Accelerated Approval of Nomlabofusp for Friedreich’s Ataxia

Larimar Therapeutics Files First Module of BLA With US FDA for Nomlabofusp

Larimar's Rare Disease Push Just Hit A Key Inflection Point — What Investors Need To Know

Larimar Therapeutics Shares Drop Following Clinical Update and Regulatory Filing (LRMR)

LRMR Shares Hold Steady As Wall Street Optimism Offsets Drug Safety Concerns

Here’s What Citi Thinks About Larimar Therapeutics (LRMR)

LRMR Stock Edges Up After Hours After Director Purchases Shares Worth About $167,000

Larimar Therapeutics (LRMR) Submits Initial Module of BLA For Nomlabofusp Therapy